Global Acne Treatment Market: Forecast till 2027
出 版 商：Market Research Future
出版日期：2021/08/01
頁 數：153頁
文件格式：PDF
價 格：
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
USD 6,250 (Global-User License)
Global Acne Treatment Market Forecast till 2027
Acne Treatment Market Overview
The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027. Acne treatment includes the organization of a few types of prescriptions and balms to ease up the tone of influenced regions. A decent eating regimen is likewise viewed as a vital factor for acne treatment, and this factor has assumed a significant part in the development of the acne treatment market. Also, the rising requirement for further developed drugs for acne treatment has acquired voluminous interests in the acne treatment market.
The global acne treatment market is anticipated to witness a healthy market growth during the review period owing to the highest market value of USD 5,383.05 million in 2019. The growth of the global market is attributed to the rising prevalence of acne vulgaris, growing sedentary lifestyle and unhealthy food habits, High influence of social media, and brand endorsements. However, security issues related to the products being applied for acne treatment and the Failure of pivotal clinical trials for key candidates are expected to restrain the global market growth during the review period.
Market Segmentation
The acne treatment market has been classified into acne type, treatment, drug type, route of administration, and end-user.
Based on acne type, the global market has been classified into moderate acne, mild acne, moderate to severe acne.
Based on Treatment Type the acne treatment market is bifurcated into medication and therapeutic devices.
In terms of Drug Type, the global acne treatment market has been divided into OTC and prescription.
In terms of acne treatment market has been segregated into hospitals & clinics and specialty centers.
Regional Analysis
Geographically, the global acne treatment market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas drove the acne treatment market in 2019 and is probably going to keep on directing during the survey time frame. This can be credited to the high predominance of acne and skin problems, item dispatches, and mechanical progression around here.
Europe stood firm on the second-biggest foothold in the acne treatment market in 2019 inferable from the natural development systems of organizations and a very much created clinical industry in the area.
The Asia Pacific is expected to register the fastest market growth during the review period followed by the Middle East and Africa.
Major Players
The Key Companies of the global acne treatment market are GlaxoSmithKline plc., Almirall, S.A., Galderma Laboratories, Hoffman La Roche Ltd, Bausch Health Companies Inc, Leo Pharma A/S, Johnson & Johnson Services Inc, Teva Pharmaceutical Industries Ltd, Candela Corporation, and Vyne Therapeutics Inc.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Acne Treatment Market Overview
The acne treatment market is expected to register a CAGR of 5.03% during the forecast period of 2020 to 2027. Acne treatment includes the organization of a few types of prescriptions and balms to ease up the tone of influenced regions. A decent eating regimen is likewise viewed as a vital factor for acne treatment, and this factor has assumed a significant part in the development of the acne treatment market. Also, the rising requirement for further developed drugs for acne treatment has acquired voluminous interests in the acne treatment market.
The global acne treatment market is anticipated to witness a healthy market growth during the review period owing to the highest market value of USD 5,383.05 million in 2019. The growth of the global market is attributed to the rising prevalence of acne vulgaris, growing sedentary lifestyle and unhealthy food habits, High influence of social media, and brand endorsements. However, security issues related to the products being applied for acne treatment and the Failure of pivotal clinical trials for key candidates are expected to restrain the global market growth during the review period.
Market Segmentation
The acne treatment market has been classified into acne type, treatment, drug type, route of administration, and end-user.
Based on acne type, the global market has been classified into moderate acne, mild acne, moderate to severe acne.
Based on Treatment Type the acne treatment market is bifurcated into medication and therapeutic devices.
In terms of Drug Type, the global acne treatment market has been divided into OTC and prescription.
In terms of acne treatment market has been segregated into hospitals & clinics and specialty centers.
Regional Analysis
Geographically, the global acne treatment market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and Middle East & Africa.
Americas drove the acne treatment market in 2019 and is probably going to keep on directing during the survey time frame. This can be credited to the high predominance of acne and skin problems, item dispatches, and mechanical progression around here.
Europe stood firm on the second-biggest foothold in the acne treatment market in 2019 inferable from the natural development systems of organizations and a very much created clinical industry in the area.
The Asia Pacific is expected to register the fastest market growth during the review period followed by the Middle East and Africa.
Major Players
The Key Companies of the global acne treatment market are GlaxoSmithKline plc., Almirall, S.A., Galderma Laboratories, Hoffman La Roche Ltd, Bausch Health Companies Inc, Leo Pharma A/S, Johnson & Johnson Services Inc, Teva Pharmaceutical Industries Ltd, Candela Corporation, and Vyne Therapeutics Inc.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 18
1.1 OVERVIEW 18
1.1.1 MARKET SYNOPSIS 18
2 MARKET INTRODUCTION 19
2.1 SCOPE OF THE STUDY 19
2.2 RESEARCH OBJECTIVE 19
2.3 LIST OF ASSUMPTIONS & LIMITATIONS 19
3 RESEARCH METHODOLOGY 21
3.1 OVERVIEW 21
3.2 DATA MINING 21
3.3 SECONDARY RESEARCH 22
3.4 PRIMARY RESEARCH 23
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24
3.5 FORECASTING TECHNIQUES 25
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25
3.6.1 BOTTOM-UP APPROACH 26
3.6.2 TOP-DOWN APPROACH 27
3.7 DATA TRIANGULATION 28
3.8 VALIDATION 28
4 MARKET DYNAMICS 29
4.1 OVERVIEW 29
4.2 DRIVERS 30
4.2.1 HIGH GLOBAL ACNE PREVALENCE 30
4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 30
4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 30
4.2.4 RISE IN THE DISPOSABLE INCOMES OF MIDDLE-CLASS PEOPLE 31
4.3 RESTRAINTS 32
4.3.1 SAFETY ISSUES REGARDING THE PRODUCTS 32
4.3.2 FAILURE OF PIVOTAL CLINICAL TRIALS FOR KEY CANDIDATES 32
4.4 OPPORTUNITIES 33
4.4.1 INCREASING AWARENESS ABOUT CURRENT AND UPCOMING ACNE TREATMENTS 33
4.5 TRENDS 33
4.5.1 ARTIFICIAL INTELLIGENCE ALGORITHM 33
4.5.2 PREFERENCE TOWARDS CLEAN SKINCARE ROUTINE 34
5 MARKET FACTOR ANALYSIS 35
5.1 VALUE CHAIN ANALYSIS 35
5.1.1 R&D AND DESIGNING 36
5.1.2 MANUFACTURING 36
5.1.3 DISTRIBUTION 36
5.1.4 MARKETING & SALES 36
5.2 PORTER’S FIVE FORCES MODEL 36
5.2.1 BARGAINING POWER OF SUPPLIERS 37
5.2.2 BARGAINING POWER OF BUYERS 37
5.2.3 THREAT OF NEW ENTRANTS 38
5.2.4 THREAT OF SUBSTITUTES 38
5.2.5 INTENSITY OF RIVALRY 38
5.3 IMPACT OF COVID-19 38
5.4 PESTEL ANALYSIS 40
6 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE 41
6.1 OVERVIEW 41
6.2 MODERATE ACNE 42
6.3 MILD ACNE 43
6.4 MODERATE TO SEVERE ACNE 43
7 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT 44
7.1 OVERVIEW 44
7.2 MEDICATION 45
7.3 THERAPEUTIC DEVICES 46
8 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE 48
8.1 OVERVIEW 48
8.2 OTC 49
8.3 PRESCRIPTION 49
9 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 50
9.1 OVERVIEW 50
9.2 TOPICAL 51
9.3 ORAL 51
9.4 INJECTABLE 52
10 GLOBAL ACNE TREATMENT MARKET, BY END USER 53
10.1 OVERVIEW 53
10.2 HOSPITALS & CLINICS 54
10.3 SPECIALTY CENTERS 54
11 GLOBAL ACNE TREATMENT MARKET, BY REGION 55
11.1 OVERVIEW 55
11.2 AMERICAS 56
11.2.1 NORTH AMERICA 59
11.2.1.1 US 62
11.2.1.2 CANADA 65
11.2.2 LATIN AMERICA 67
11.3 EUROPE 70
11.3.1 WESTERN EUROPE 73
11.3.1.1 GERMANY 76
11.3.1.2 FRANCE 79
11.3.1.3 UK 80
11.3.1.4 ITALY 82
11.3.1.5 SPAIN 84
11.3.1.6 REST OF WESTERN EUROPE 86
11.3.2 EASTERN EUROPE 89
11.4 ASIA-PACIFIC 92
11.4.1 CHINA 95
11.4.2 JAPAN 98
11.4.3 INDIA 100
11.4.4 AUSTRALIA 102
11.4.5 SOUTH KOREA 104
11.4.6 REST OF ASIA-PACIFIC 106
11.5 MIDDLE EAST & AFRICA 109
11.5.1 MIDDLE EAST 112
11.5.2 AFRICA 115
12 COMPETITIVE LANDSCAPE 117
12.1 OVERVIEW 117
12.2 LEADING MARKET PLAYERS 117
12.3 GLOBAL ACNE TREATMENT MARKET SHARE ANALYSIS (2019) 118
12.4 COMPETITIVE BENCHMARKING 119
12.4.1 APPROVAL 120
12.4.2 PRODUCT LAUNCH 120
12.4.3 EXPANSION & ACQUISITION 121
12.4.4 AGREEMENT 121
12.5 LIST OF COMPANIES AND THEIR PRODUCTS FOR ACNE TREATMENT 122
13 COMPANY PROFILES 126
13.1 GLAXOSMITHKLINE PLC 126
13.1.1 COMPANY OVERVIEW 126
13.1.2 FINANCIAL OVERVIEW 127
13.1.3 PRODUCTS/SERVICES OFFERED 127
13.1.4 KEY DEVELOPMENTS 128
13.1.5 SWOT ANALYSIS 128
13.1.6 KEY STRATEGIES 128
13.2 ALMIRALL, S.A. 129
13.2.1 COMPANY OVERVIEW 129
13.2.2 FINANCIAL OVERVIEW 129
13.2.3 PRODUCTS/SERVICES OFFERED 130
13.2.4 ALMIRALL, S.A: KEY DEVELOPMENTS 130
13.2.5 SWOT ANALYSIS 131
13.2.6 KEY STRATEGIES 131
13.3 GALDERMA LABORATORIES, L.P. 132
13.3.1 COMPANY OVERVIEW 132
13.3.2 FINANCIAL OVERVIEW 132
13.3.3 PRODUCTS/SERVICES OFFERED 132
13.3.4 KEY DEVELOPMENTS 133
13.3.5 SWOT ANALYSIS 133
13.3.6 KEY STRATEGIES 133
13.4 F. HOFFMAN LA ROCHE LTD 134
13.4.1 COMPANY OVERVIEW 134
13.4.2 FINANCIAL OVERVIEW 135
13.4.3 PRODUCTS/SERVICES OFFERED 135
13.4.4 KEY DEVELOPMENTS 135
13.4.5 SWOT ANALYSIS 136
13.4.6 KEY STRATEGIES 136
13.5 BAUSCH HEALTH COMPANIES INC. 137
13.5.1 COMPANY OVERVIEW 137
13.5.2 FINANCIAL OVERVIEW 137
13.5.3 PRODUCTS/SERVICES OFFERED 138
13.5.4 KEY DEVELOPMENTS 138
13.5.5 SWOT ANALYSIS 139
13.5.6 KEY STRATEGIES 139
13.6 LEO PHARMA A/S 140
13.6.1 COMPANY OVERVIEW 140
13.6.2 FINANCIAL OVERVIEW 140
13.6.3 PRODUCTS/SERVICES OFFERED 141
13.6.4 KEY DEVELOPMENTS 141
13.6.5 SWOT ANALYSIS 141
13.6.6 KEY STRATEGIES 142
13.7 JOHNSON & JOHNSON SERVICES INC. 143
13.7.1 COMPANY OVERVIEW 143
13.7.2 FINANCIAL OVERVIEW 143
13.7.3 PRODUCTS/SERVICES OFFERED 144
13.7.4 KEY DEVELOPMENTS 144
13.7.5 SWOT ANALYSIS 144
13.7.6 KEY STRATEGIES 145
13.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 146
13.8.1 COMPANY OVERVIEW 146
13.8.2 FINANCIAL OVERVIEW 146
13.8.3 PRODUCTS/SERVICES OFFERED 147
13.8.4 KEY DEVELOPMENTS 147
13.8.5 SWOT ANALYSIS 147
13.8.6 KEY STRATEGIES 148
13.9 CANDELA CORPORATION 149
13.9.1 COMPANY OVERVIEW 149
13.9.2 FINANCIAL OVERVIEW 149
13.9.3 PRODUCTS/SERVICES OFFERED 149
13.9.4 KEY DEVELOPMENTS 149
13.9.5 SWOT ANALYSIS 150
13.9.6 KEY STRATEGIES 150
13.10 VYNE THERAPEUTICS INC. 151
13.10.1 COMPANY OVERVIEW 151
13.10.2 FINANCIAL OVERVIEW 151
13.10.3 PRODUCTS/SERVICES OFFERED 151
13.10.4 KEY DEVELOPMENTS 152
13.10.5 SWOT ANALYSIS 152
13.10.6 KEY STRATEGIES 152
?
14 APPENDIX 153
14.1 REFERENCES 153
14.2 RELATED REPORTS 153
1 EXECUTIVE SUMMARY 18
1.1 OVERVIEW 18
1.1.1 MARKET SYNOPSIS 18
2 MARKET INTRODUCTION 19
2.1 SCOPE OF THE STUDY 19
2.2 RESEARCH OBJECTIVE 19
2.3 LIST OF ASSUMPTIONS & LIMITATIONS 19
3 RESEARCH METHODOLOGY 21
3.1 OVERVIEW 21
3.2 DATA MINING 21
3.3 SECONDARY RESEARCH 22
3.4 PRIMARY RESEARCH 23
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24
3.5 FORECASTING TECHNIQUES 25
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25
3.6.1 BOTTOM-UP APPROACH 26
3.6.2 TOP-DOWN APPROACH 27
3.7 DATA TRIANGULATION 28
3.8 VALIDATION 28
4 MARKET DYNAMICS 29
4.1 OVERVIEW 29
4.2 DRIVERS 30
4.2.1 HIGH GLOBAL ACNE PREVALENCE 30
4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 30
4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 30
4.2.4 RISE IN THE DISPOSABLE INCOMES OF MIDDLE-CLASS PEOPLE 31
4.3 RESTRAINTS 32
4.3.1 SAFETY ISSUES REGARDING THE PRODUCTS 32
4.3.2 FAILURE OF PIVOTAL CLINICAL TRIALS FOR KEY CANDIDATES 32
4.4 OPPORTUNITIES 33
4.4.1 INCREASING AWARENESS ABOUT CURRENT AND UPCOMING ACNE TREATMENTS 33
4.5 TRENDS 33
4.5.1 ARTIFICIAL INTELLIGENCE ALGORITHM 33
4.5.2 PREFERENCE TOWARDS CLEAN SKINCARE ROUTINE 34
5 MARKET FACTOR ANALYSIS 35
5.1 VALUE CHAIN ANALYSIS 35
5.1.1 R&D AND DESIGNING 36
5.1.2 MANUFACTURING 36
5.1.3 DISTRIBUTION 36
5.1.4 MARKETING & SALES 36
5.2 PORTER’S FIVE FORCES MODEL 36
5.2.1 BARGAINING POWER OF SUPPLIERS 37
5.2.2 BARGAINING POWER OF BUYERS 37
5.2.3 THREAT OF NEW ENTRANTS 38
5.2.4 THREAT OF SUBSTITUTES 38
5.2.5 INTENSITY OF RIVALRY 38
5.3 IMPACT OF COVID-19 38
5.4 PESTEL ANALYSIS 40
6 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE 41
6.1 OVERVIEW 41
6.2 MODERATE ACNE 42
6.3 MILD ACNE 43
6.4 MODERATE TO SEVERE ACNE 43
7 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT 44
7.1 OVERVIEW 44
7.2 MEDICATION 45
7.3 THERAPEUTIC DEVICES 46
8 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE 48
8.1 OVERVIEW 48
8.2 OTC 49
8.3 PRESCRIPTION 49
9 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 50
9.1 OVERVIEW 50
9.2 TOPICAL 51
9.3 ORAL 51
9.4 INJECTABLE 52
10 GLOBAL ACNE TREATMENT MARKET, BY END USER 53
10.1 OVERVIEW 53
10.2 HOSPITALS & CLINICS 54
10.3 SPECIALTY CENTERS 54
11 GLOBAL ACNE TREATMENT MARKET, BY REGION 55
11.1 OVERVIEW 55
11.2 AMERICAS 56
11.2.1 NORTH AMERICA 59
11.2.1.1 US 62
11.2.1.2 CANADA 65
11.2.2 LATIN AMERICA 67
11.3 EUROPE 70
11.3.1 WESTERN EUROPE 73
11.3.1.1 GERMANY 76
11.3.1.2 FRANCE 79
11.3.1.3 UK 80
11.3.1.4 ITALY 82
11.3.1.5 SPAIN 84
11.3.1.6 REST OF WESTERN EUROPE 86
11.3.2 EASTERN EUROPE 89
11.4 ASIA-PACIFIC 92
11.4.1 CHINA 95
11.4.2 JAPAN 98
11.4.3 INDIA 100
11.4.4 AUSTRALIA 102
11.4.5 SOUTH KOREA 104
11.4.6 REST OF ASIA-PACIFIC 106
11.5 MIDDLE EAST & AFRICA 109
11.5.1 MIDDLE EAST 112
11.5.2 AFRICA 115
12 COMPETITIVE LANDSCAPE 117
12.1 OVERVIEW 117
12.2 LEADING MARKET PLAYERS 117
12.3 GLOBAL ACNE TREATMENT MARKET SHARE ANALYSIS (2019) 118
12.4 COMPETITIVE BENCHMARKING 119
12.4.1 APPROVAL 120
12.4.2 PRODUCT LAUNCH 120
12.4.3 EXPANSION & ACQUISITION 121
12.4.4 AGREEMENT 121
12.5 LIST OF COMPANIES AND THEIR PRODUCTS FOR ACNE TREATMENT 122
13 COMPANY PROFILES 126
13.1 GLAXOSMITHKLINE PLC 126
13.1.1 COMPANY OVERVIEW 126
13.1.2 FINANCIAL OVERVIEW 127
13.1.3 PRODUCTS/SERVICES OFFERED 127
13.1.4 KEY DEVELOPMENTS 128
13.1.5 SWOT ANALYSIS 128
13.1.6 KEY STRATEGIES 128
13.2 ALMIRALL, S.A. 129
13.2.1 COMPANY OVERVIEW 129
13.2.2 FINANCIAL OVERVIEW 129
13.2.3 PRODUCTS/SERVICES OFFERED 130
13.2.4 ALMIRALL, S.A: KEY DEVELOPMENTS 130
13.2.5 SWOT ANALYSIS 131
13.2.6 KEY STRATEGIES 131
13.3 GALDERMA LABORATORIES, L.P. 132
13.3.1 COMPANY OVERVIEW 132
13.3.2 FINANCIAL OVERVIEW 132
13.3.3 PRODUCTS/SERVICES OFFERED 132
13.3.4 KEY DEVELOPMENTS 133
13.3.5 SWOT ANALYSIS 133
13.3.6 KEY STRATEGIES 133
13.4 F. HOFFMAN LA ROCHE LTD 134
13.4.1 COMPANY OVERVIEW 134
13.4.2 FINANCIAL OVERVIEW 135
13.4.3 PRODUCTS/SERVICES OFFERED 135
13.4.4 KEY DEVELOPMENTS 135
13.4.5 SWOT ANALYSIS 136
13.4.6 KEY STRATEGIES 136
13.5 BAUSCH HEALTH COMPANIES INC. 137
13.5.1 COMPANY OVERVIEW 137
13.5.2 FINANCIAL OVERVIEW 137
13.5.3 PRODUCTS/SERVICES OFFERED 138
13.5.4 KEY DEVELOPMENTS 138
13.5.5 SWOT ANALYSIS 139
13.5.6 KEY STRATEGIES 139
13.6 LEO PHARMA A/S 140
13.6.1 COMPANY OVERVIEW 140
13.6.2 FINANCIAL OVERVIEW 140
13.6.3 PRODUCTS/SERVICES OFFERED 141
13.6.4 KEY DEVELOPMENTS 141
13.6.5 SWOT ANALYSIS 141
13.6.6 KEY STRATEGIES 142
13.7 JOHNSON & JOHNSON SERVICES INC. 143
13.7.1 COMPANY OVERVIEW 143
13.7.2 FINANCIAL OVERVIEW 143
13.7.3 PRODUCTS/SERVICES OFFERED 144
13.7.4 KEY DEVELOPMENTS 144
13.7.5 SWOT ANALYSIS 144
13.7.6 KEY STRATEGIES 145
13.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 146
13.8.1 COMPANY OVERVIEW 146
13.8.2 FINANCIAL OVERVIEW 146
13.8.3 PRODUCTS/SERVICES OFFERED 147
13.8.4 KEY DEVELOPMENTS 147
13.8.5 SWOT ANALYSIS 147
13.8.6 KEY STRATEGIES 148
13.9 CANDELA CORPORATION 149
13.9.1 COMPANY OVERVIEW 149
13.9.2 FINANCIAL OVERVIEW 149
13.9.3 PRODUCTS/SERVICES OFFERED 149
13.9.4 KEY DEVELOPMENTS 149
13.9.5 SWOT ANALYSIS 150
13.9.6 KEY STRATEGIES 150
13.10 VYNE THERAPEUTICS INC. 151
13.10.1 COMPANY OVERVIEW 151
13.10.2 FINANCIAL OVERVIEW 151
13.10.3 PRODUCTS/SERVICES OFFERED 151
13.10.4 KEY DEVELOPMENTS 152
13.10.5 SWOT ANALYSIS 152
13.10.6 KEY STRATEGIES 152
?
14 APPENDIX 153
14.1 REFERENCES 153
14.2 RELATED REPORTS 153
